Valuation: Amedica Corporation

Market Cap 7.43M 6.52M 6.04M 5.55M 10.5M 711M 10.71M 71.93M 28.21M 349M 27.9M 27.29M 1.21B P/E 2026 *
-0.8x
P/E 2027 * -1.2x
Enterprise Value 7.43M 6.52M 6.04M 5.55M 10.5M 711M 10.71M 71.93M 28.21M 349M 27.9M 27.29M 1.21B EV / Sales 2026 *
3.23x
EV / Sales 2027 * 1.41x
Free-Float
65.08%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2007
President - 16/03/2026
Director of Finance/CFO 41 04/09/2025
Director TitleAgeSince
Director/Board Member 63 01/12/2007
Director/Board Member 63 03/04/2025
Director/Board Member 72 05/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.20%+2.62%-14.88%+11.21% 126B
+1.27%+1.63%+3.17%-1.24% 12.9B
+0.54%+3.01%+47.02%+113.82% 8.97B
-2.84%-5.15%-50.08%-72.78% 3.98B
+1.52%+0.15%+22.38%+47.77% 2.7B
-5.07%-12.37%-19.07%-27.93% 1.74B
-1.19%-5.02%-7.21%-24.81% 1.61B
-0.94%+3.28%-60.79%-84.21% 1.49B
Average -0.65%+0.99%-9.93%-4.77% 19.98B
Weighted average by Cap. +0.99%+1.07%-10.59%+12.81%

Financials

2026 *2027 *
Net sales 2.3M 2.02M 1.87M 1.72M 3.26M 220M 3.32M 22.3M 8.75M 108M 8.65M 8.46M 374M 5.27M 4.62M 4.28M 3.94M 7.45M 504M 7.59M 51M 20M 248M 19.78M 19.35M 855M
Net income -12.38M -10.86M -10.06M -9.25M -17.5M -1.18B -17.84M -120M -47.01M -582M -46.48M -45.47M -2.01B -11.38M -9.98M -9.24M -8.5M -16.08M -1.09B -16.4M -110M -43.2M -535M -42.72M -41.79M -1.85B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-